AndroGel Antitrust Case On Hold Amid Settlement Talk

By Jared Foretek · September 19, 2024, 9:09 PM EDT

A Pennsylvania federal judge has agreed to pause a class action against Abbott and other drugmakers over allegedly sham patent cases, saying a settlement between the two sides may be in...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Order

Case Information

Case Title

KING DRUG COMPANY OF FLORENCE, INC. et al v. ABBOTT LABORATORIES et al

Case Number

Court

Pennsylvania Eastern

Nature of Suit

Other Statutes: Anti-Trust

Date Filed

August 07, 2019

Recent Articles By Jared

November 14, 2024
Emergency Medical Providers Oppose $2.8B BCBS Deal
October 28, 2024
Hospital Wants NC County's 'Monopoly' Suit Tossed
October 09, 2024
CVS, United Health Seek Removal Of FTC's Khan In PBM Case
October 01, 2024
DOJ Joins Employee Antitrust Suit Against UPMC
September 25, 2024
DC Circ. Judges Ask If It's Too Late To Fast-Track Gastro Drug
September 05, 2024
Judge Orders Jury Trial Over Arbitration Bid In TCPA Fight
August 30, 2024
Period Tracker App Users Seek Class Cert. In Data-Selling Suit
August 26, 2024
FTC Mulls Proposal To Alter Puerto Rican Pharmacy Deal
August 15, 2024
Medical Records Co. Appealing Blocked Anti-Bot CAPTCHAs
August 12, 2024
States Want Teva Generic Price Fixing Case Tried 1st